Rapidly changing landscape of diabetic kidney disease management: recent advances and the road ahead
{{output}}
Diabetic kidney disease (DKD) management has advanced rapidly in recent years, with new therapies supplementing established treatments. The cardiorenal benefits of sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (G... ...
